Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST)

Contemporary Clinical Trials

Volumn 34, Issue 1, 2013, Pages 136-144

  Jain, Nishank ^a,b   Trivedi, Madhukar H ^c   Rush, A John ^d   Carmody, Thomas ^c   Kurian, Benji ^c   Toto, Robert D ^b   Sarode, Ravindra ^b   Hedayati, S Susan ^a,b  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Chronic kidney disease; Depression; Randomized trial; Sertraline; Treatment

Indexed keywords

PLACEBO; SERTRALINE;

ARTICLE; CHRONIC KIDNEY DISEASE; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; MAJOR DEPRESSION; PATIENT COMPLIANCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SERTRALINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84870518975     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2012.10.004     Document Type: Article

References (64)

1. Snow V., Lascher S., Mottur-Pilson C. Pharmacologic treatment of acute major depression and dysthymia. American College of Physicians-American Society of Internal Medicine. Ann Intern Med 2000, 132:738-742.
2. Hedayati S.S., Minhajuddin A.T., Toto R.D., Morris D.W., Rush A.J. Validation of depression screening scales in patients with CKD. Am J Kidney Dis 2009, 54:433-439.
3. Hedayati S.S., Minhajuddin A.T., Toto R.D., Morris D.W., Rush A.J. Prevalence of major depressive episode in CKD. Am J Kidney Dis 2009, 54:424-432.
4. Hedayati S.S., Finkelstein F.O. Epidemiology, diagnosis, and management of depression in patients with CKD. Am J Kidney Dis 2009, 54:741-752.
5. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., et al. The epidemiology of major depressive disorder. JAMA 2003, 289:3095-3105.
6. Anderson R.J., Freedland K.E., Clouse R.E., Lustman P.J. The prevalence of comorbid depression in adults with diabetes. Diabetes Care 2001, 24:1069-1078.
7. Jiang W., Alexander J., Christopher E., Kuchibhatla M., Gaulden L.H., Cuffe M.S., et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001, 161:1849-1856.
8. Jiang W., O'Connor C., Silva S.G., Kuchibhatla M., Cuffe M.S., Callwood D.D., et al. Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure. Am Heart J 2008, 156:437-444.
9. Lopes A.A., Bragg J., Young E., Goodkin D., Mapes D., Combe C., et al. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int 2002, 62:199-207.
10. Walters B.A.J., Hays R.D., Spritzer K.L., Fridman M., Carter W.B. Health-related quality of life, depressive symptoms, anemia, and malnutrition at hemodialysis initiation. Am J Kidney Dis 2002, 40:1185-1194.
11. Drayer R.A., Piraino B., Reynolds Iii C.F., Houck P.R., Mazumdar S., Bernardini J., et al. Characteristics of depression in hemodialysis patients: symptoms, quality of life and mortality risk. Gen Hosp Psychiatry 2006, 28:306-312.
12. Peng Y.-S., Chiang C.-K., Hung K.-Y., Chiang S.-S., Lu C.-S., Yang C.-S., et al. The association of higher depressive symptoms and sexual dysfunction in male haemodialysis patients. Nephrol Dial Transplant 2007, 22:857-861.
13. Hedayati S.S., Bosworth H.B., Briley L.P., Sloane R.J., Pieper C.F., Kimmel P.L., et al. Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. Kidney Int 2008, 74:930-936.
14. Kimmel P.L., Peterson R.A., Weihs K.L., Simmens S.J., Alleyne S., Cruz I., et al. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int 2000, 57:2093-2098.
15. Boulware L.E., Liu Y., Fink N.E., Coresh J., Ford D.E., Klag M.J., et al. Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality. Clin J Am Soc Nephrol 2006, 1:496-504.
16. Hedayati S.S., Minhajuddin A.T., Afshar M., Toto R.D., Trivedi M.H., Rush A.J. Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death. JAMA 2010, 303:1946-1953.
17. Herrera-Guzman I., Gudayol-Ferre E., Herrera-Guzman D., Guardia-Olmos J., Hinojosa-Calvo E., Herrera-Abarca J.E. Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder. J Psychiatr Res 2009, 43:855-863.
18. Kurella M., Chertow G.M., Fried L.F., Cummings S.R., Harris T., Simonsick E., et al. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol 2005, 16:2127-2133.
19. Serebruany V.L., Glassman A.H., Malinin A.I., Atar D., Sane D.C., Oshrine B.R., et al. Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin. Eur J Heart Fail 2003, 5:517-521.
20. Serebruany V.L., Glassman A.H., Malinin A.I., Sane D.C., Finkel M.S., Krishnan R.R., et al. Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials. Blood Coagul Fibrinolysis 2003, 14:563-567.
21. Koo J.R., Yoon J.W., Kim S.G., Lee Y.K., Oh K.H., Kim G.H., et al. Association of depression with malnutrition in chronic hemodialysis patients. Am J Kidney Dis 2003, 41:1037-1042.
22. Everett K.D., Brantley P.J., Sletten C., Jones G.N., McKnight G.T. The relation of stress and depression to interdialytic weight gain in hemodialysis patients. Behav Med 1995, 21:25-30.
23. Sensky T., Leger C., Gilmour S. Psychosocial and cognitive factors associated with adherence to dietary and fluid restriction regimens by people on chronic haemodialysis. Psychother Psychosom 1996, 65:36-42.
24. Hedayati S.S., Bosworth H.B., Kuchibhatla M., Kimmel P.L., Szczech L.A. The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int 2006, 69:1662-1668.
25. Watnick S., Kirwin P., Mahnensmith R. The prevalence and treatment of depression among patients starting dialysis. Am J Kidney Dis 2003, 41:105-110.
26. Lopes A.A., Albert J.M., Young E.W., Satayathum S., Pisoni R.L., Andreucci V.E., et al. Screening for depression in hemodialysis patients: associations with diagnosis, treatment, and outcomes in the DOPPS. Kidney Int 2004, 66:2047-2053.
27. Yuan Y., Tsoi K., Hunt R.H. Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding?. Am J Med 2006, 119:719-727.
28. Cohen L.M., Tessier E.G., Germain M.J., Levy N.B. Update on psychotropic medication use in renal disease. Psychosomatics 2004, 45:34-48.
29. Dalton S.O., Johansen C., Mellemkjaer L., Norgard B., Sorensen H.T., Olsen J.H. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 2003, 163:59-64.
30. Wuerth D., Finkelstein S.H., Finkelstein F.O. The identification and treatment of depression in patients maintained on dialysis. Semin Dial 2005, 18:142-146.
31. Turk S., Atalay H., Altintepe L., Güney I., Okudan N., Tonbul H., et al. Treatment with antidepressive drugs improved quality of life in chronic hemodialysis patients. Clin Nephrol 2006, 65:113-118.
32. Wuerth D., Finkelstein S.H., Ciarcia J., Peterson R., Kliger A.S., Finkelstein F.O. Identification and treatment of depression in a cohort of patients maintained on chronic peritoneal dialysis. Am J Kidney Dis 2001, 37:1011-1017.
33. Koo J.-R., Yoon J.-Y., Joo M.-H., Lee H.-S., Oh J.-E., Kim S.-G., et al. Treatment of depression and effect of antidepression treatment on nutritional status in chronic hemodialysis patients. Am J Med Sci 2005, 329:1-5.
34. Glassman A.H., O'Connor C.M., Califf R.M., Swedberg K., Schwartz P., Bigger J.T., et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002, 288:701-709.
35. Clinical Trials Identifier Number NCT00946998 Clinical Trials [Accessed on February 20 2012]. http://www.clinicaltrials.gov/.
36. Rush A.J., Trivedi M.H., Ibrahim H.M., Carmody T.J., Arnow B., Klein D.N., et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003, 54:573-583.
37. Inventory of Depressive Symptomatology (IDS), Quick Inventory of Depressive Symptomatology (QIDS) [Accessed on April 2 2012]. http://www.ids-qids.org/.
38. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(Suppl. 20):22-33. [quiz 4-57].
39. Amorim P., Lecrubier Y., Weiller E., Hergueta T., Sheehan D. DSM-IH-R Psychotic Disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI. Eur Psychiatry 1998, 13:26-34.
40. Cukor D. Use of CBT to treat depression among patients on hemodialysis. Psychiatr Serv 2007, 58:711-712.
41. van Vilsteren M.C., de Greef M.H., Huisman R.M. The effects of a low-to-moderate intensity pre-conditioning exercise programme linked with exercise counselling for sedentary haemodialysis patients in The Netherlands: results of a randomized clinical trial. Nephrol Dial Transplant 2005, 20:141-146.
42. Hedayati S.S., Yalamanchili V., Finkelstein F.O. A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. Kidney Int 2012, 81:247-255.
43. Harding K.J., Rush A.J., Arbuckle M., Trivedi M.H., Pincus H.A. Measurement-based care in psychiatry practice: a policy framework for implementation. J Clin Psychiatry 2011, 72:1136-1143.
44. Morris D.W., Trivedi M.H. Measurement-based care for unipolar depression. Curr Psychiatry Rep 2011, 13:446-458.
45. Trivedi M.H., Fava M., Wisniewski S.R., Thase M.E., Quitkin F., Warden D., et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med 2006, 354:1243-1252.
46. Trivedi M.H., Rush A.J., Wisniewski S.R., Nierenberg A.A., Warden D., Ritz L., et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006, 163:28-40.
47. Wisniewski S.R., Rush A.J., Balasubramani G.K., Trivedi M.H., Nierenberg A.A. Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract 2006, 12:71-79.
48. Diler R.S., Avci A. Selective serotonin reuptake inhibitors in children and adolescents. Swiss Med Wkly 2002, 132:470-477.
49. Mundt J.C., Marks I.M., Shear M.K., Greist J.H. The work and social adjustment scale: a simple measure of impairment in functioning. Br J Psychiatry 2002, 180:461-464.
50. Mataix-Cols D., Cowley A.J., Hankins M., Schneider A., Bachofen M., Kenwright M., et al. Reliability and validity of the Work and Social Adjustment Scale in phobic disorders. Compr Psychiatry 2005, 46:223-228.
51. Hays R., Kallich J., Mapes D., Coons S., Carter W. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res 1994, 3:329-338.
52. Levine J., Schooler N.R. SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull 1986, 22:343-381.
53. Serebruany V., Suckow R., Cooper T., O'Connor C., Malinin A., Krishnan K., et al. Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. Am J Psychiatry 2005, 162:1165-1170.
54. Alderman C., Moritz C., Ben-Tovim D. Abnormal platelet aggregation associated with fluoxetine therapy. Ann Pharmacother 1992, 26:1517-1519.
55. Morisky E., Green L., Levine D. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24:67-74.
56. Sreedhara R., Avram M.M., Blanco M., Batish R., Mittman N. Prealbumin is the best nutritional predictor of survival in hemodialysis and peritoneal dialysis. Am J Kidney Dis 1996, 28:937-942.
57. Cooper B.A., Penne E.L., Bartlett L.H., Pollock C.A. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis 2004, 43:61-66.
58. Dyszkiewicz-Korpanty A.M., Frenkel E.P., Sarode R. Approach to the assessment of platelet function: comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methods. Clin Appl Thromb Hemost 2005, 11:25-35.
59. Gibbons R.D., Hedeker D., Elkin I., Waternaux C., Kraemer H.C., Greenhouse J.B., et al. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset. Arch Gen Psychiatry 1993, 50:739-750.
60. Curran D., Molenberghs G., Thijs H., Verbeke G. Sensitivity analysis for pattern mixture models. J Biopharm Stat 2004, 14:125-143.
61. Brown E.S., Vigil L., Khan D.A., Liggin J.D., Carmody T.J., Rush A.J. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study. Biol Psychiatry 2005, 58:865-870.
62. O'Connor C.M., Jiang W., Kuchibhatla M., Silva S.G., Cuffe M.S., Callwood D.D., et al. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 2010, 56:692-699.
63. Cohen S.D., Norris L., Acquaviva K., Peterson R.A., Kimmel P.L. Screening, diagnosis, and treatment of depression in patients with end-stage renal disease. Clin J Am Soc Nephrol 2007, 2:1332-1342.
64. Cohen S., Perkins V., Kimmel P. Psychosocial issues in ESRD patients. Handbook of Dialysis tE 2007, 455-461. Little Brown, Boston. J. Daugirdas, T. Ing (Eds.).